Transgelin promotes lung cancer progression via activation of cancer-associated fibroblasts with enhanced IL-6 release.

Oncogenesis · 2023 · PMC10060230 · PMID 36990991

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Treatment with anti-IL6 promoted a decreasing trend in tumor volume and weight (Fig. 7E, F ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.